Unit profile
Description
Protecting the borders is vital no matter the scale – be it a country, a private yard, or a living flesh. Every organism has its defense system and that is immunity. Yet, what immune mechanisms defend our borders from invaders simultaneously allowing for effective colonization by symbionts is a matter of debate. Mucocutaneous barrier is our physical border that is occupied by trillions of commensal microbes that respond to environmental stimuli and interact with tissue immunity. The most effective immune defense is antibody production. Lab’s research focuses on cellular immunity and antibody development in barrier tissues such as the skin and the gut in response to non-inflammatory colonization with commensal microbiota, infection, and barrier vaccination. Although antibody mediated immunity is most effective weaponry in immunity’s arsenal, too much of uncontrolled rearmament might cause tissue pathology. Lab seeks to understand the factors that control balanced tissue response.
Profiles
Research output
- 1 Review article
-
Tertiary Lymphoid Organs at the Center Stage of Skin's Humoral Immunity
Gribonika, I., 2025 Sept, In: Immunological Reviews. 334, 1, e70061.Research output: Contribution to journal › Review article › peer-review
Open Access
Projects
- 2 Active
-
-
Microbiota control of skin's humoral immunity
Gribonika, I. (PI)
Svenska Sällskapet för Medicinsk Forskning
2026/01/01 → 2030/12/31
Project: Research
Activities
- 3 Presentation
-
Cutaneous antibody production regulates host-microbiota interaction
Gribonika, I. (Role not specified)
2025 Oct 15Activity: Talk or presentation › Presentation
-
Cutaneous antibody production regulates host-microbiota interaction
Gribonika, I. (Role not specified)
2025 Aug 27Activity: Talk or presentation › Presentation
-
Skin’s humoral immunity controls host-microbiota interaction
Gribonika, I. (Role not specified)
2025 Jul 21Activity: Talk or presentation › Presentation
Prizes and distinction
-
Best short talk prize at EMBO workshop: Adaptive immunity in barrier tissues
Gribonika, I. (Recipient), 2025 Aug 29
Prize: Other distinction
-
Best short talk prize at 13th European Mucosal Immunology Group Meeting
Gribonika, I. (Recipient), 2025 Jul 23
Prize: Other distinction